These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24850614)

  • 1. Neutralization of interleukin-9 ameliorates symptoms of experimental autoimmune myasthenia gravis in rats by decreasing effector T cells and altering humoral responses.
    Yao X; Kong Q; Xie X; Wang J; Li N; Liu Y; Sun B; Li Y; Wang G; Li W; Qu S; Zhao H; Wang D; Liu X; Zhang Y; Mu L; Li H
    Immunology; 2014 Nov; 143(3):396-405. PubMed ID: 24850614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous IL-9 Ameliorates Experimental Autoimmune Myasthenia Gravis Symptoms in Rats.
    Yao X; Zhao J; Kong Q; Xie X; Wang J; Sun B; Xu L; Mu L; Li H
    Immunol Invest; 2018 Oct; 47(7):712-724. PubMed ID: 29944018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATRA alters humoral responses associated with amelioration of EAMG symptoms by balancing Tfh/Tfr helper cell profiles.
    Xie X; Mu L; Yao X; Li N; Sun B; Li Y; Zhan X; Wang X; Kang X; Wang J; Liu Y; Zhang Y; Wang G; Wang D; Liu X; Kong Q; Li H
    Clin Immunol; 2013 Aug; 148(2):162-76. PubMed ID: 23773919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis.
    Mu L; Sun B; Kong Q; Wang J; Wang G; Zhang S; Wang D; Liu Y; Liu Y; An H; Li H
    Immunology; 2009 Sep; 128(1 Suppl):e826-36. PubMed ID: 19740344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic administration of fingolimod (FTY720) ameliorated experimental autoimmune myasthenia gravis by reducing the number of dendritic cells, follicular T helper cells and antibody-secreting cells.
    Liu Y; Yang CL; Yang B; Du T; Li XL; Zhang P; Ge MR; Lian Y; Li H; Liu YD; Duan RS
    Int Immunopharmacol; 2021 Jul; 96():107511. PubMed ID: 33915521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase-1 inhibitor regulates humoral responses in experimental autoimmune myasthenia gravis via IL-6- dependent inhibiton of STAT3.
    Wang CC; Zhang M; Li H; Li XL; Yue LT; Zhang P; Liu RT; Chen H; Li YB; Duan RS
    Neurosci Lett; 2017 Aug; 656():169-176. PubMed ID: 28743581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of T Follicular Helper Cell-Mediated Humoral Immunity Reponses During Development of Experimental Autoimmune Myasthenia Gravis.
    Cui YZ; Qu SY; Chang LL; Zhao JR; Mu L; Sun B; Li HL; Zhang TS; Wang GY; Kong QF
    Neurosci Bull; 2019 Jun; 35(3):507-518. PubMed ID: 30796753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leflunomide ameliorates experimental autoimmune myasthenia gravis by regulating humoral and cellular immune responses.
    Huang H; Ran H; Liu X; Yu L; Qiu L; Lin Z; Ou C; Lu Y; Yang W; Liu W
    Int Immunopharmacol; 2021 Apr; 93():107434. PubMed ID: 33556668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A deleterious role for Th9/IL-9 in hepatic fibrogenesis.
    Qin SY; Lu DH; Guo XY; Luo W; Hu BL; Huang XL; Chen M; Wang JX; Ma SJ; Yang XW; Jiang HX; Zhou Y
    Sci Rep; 2016 Jan; 6():18694. PubMed ID: 26728971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile.
    Yang H; Zhang Y; Wu M; Li J; Zhou W; Li G; Li X; Xiao B; Christadoss P
    Inflamm Res; 2010 Mar; 59(3):197-205. PubMed ID: 19768385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis.
    Aricha R; Mizrachi K; Fuchs S; Souroujon MC
    J Autoimmun; 2011 Mar; 36(2):135-41. PubMed ID: 21193288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AEB-071 Ameliorates Muscle Weakness by Altering Helper T Lymphocytes in an Experimental Autoimmune Myasthenia Gravis Rat Model.
    Jing F; Huang W; Ma Q; Xu SJ; Wu CJ; Guan YX; Chen B
    Med Sci Monit; 2020 Sep; 26():e924393. PubMed ID: 32920588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18.
    Im SH; Barchan D; Maiti PK; Raveh L; Souroujon MC; Fuchs S
    FASEB J; 2001 Oct; 15(12):2140-8. PubMed ID: 11641240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines.
    Li XL; Liu Y; Cao LL; Li H; Yue LT; Wang S; Zhang M; Li XH; Dou YC; Duan RS
    Mol Cell Neurosci; 2013 Sep; 56():85-95. PubMed ID: 23541702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR5-negative natural killer cells ameliorate experimental autoimmune myasthenia gravis by suppressing follicular helper T cells.
    Yang CL; Zhang P; Liu RT; Zhang N; Zhang M; Li H; Du T; Li XL; Dou YC; Duan RS
    J Neuroinflammation; 2019 Dec; 16(1):282. PubMed ID: 31884963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of interleukin-9 ameliorates symptoms of allergic rhinitis by reducing Th2, Th9, and Th17 responses and increasing the Treg response in a murine model.
    Gu ZW; Wang YX; Cao ZW
    Oncotarget; 2017 Feb; 8(9):14314-14324. PubMed ID: 28187441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting HIF-1α alleviates the inflammatory responses and rebuilds the CD4
    Yu L; Ran H; Lu Y; Ma Q; Huang H; Liu W
    Life Sci; 2024 Jan; 336():122287. PubMed ID: 37995933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO.
    Kong QF; Sun B; Wang GY; Zhai DX; Mu LL; Wang DD; Wang JH; Li R; Li HL
    Eur J Immunol; 2009 Mar; 39(3):800-9. PubMed ID: 19283707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 9 antagonist suppresses humoral immunity in experimental autoimmune myasthenia gravis.
    Zhang P; Yang CL; Liu RT; Li H; Zhang M; Zhang N; Yue LT; Wang CC; Dou YC; Duan RS
    Mol Immunol; 2018 Feb; 94():200-208. PubMed ID: 29331804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ONX-0914, a selective inhibitor of immunoproteasome, ameliorates experimental autoimmune myasthenia gravis by modulating humoral response.
    Liu RT; Zhang P; Yang CL; Pang Y; Zhang M; Zhang N; Yue LT; Li XL; Li H; Duan RS
    J Neuroimmunol; 2017 Oct; 311():71-78. PubMed ID: 28844501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.